ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.679
-0.06%
Brent Oil
82.44
0.56%
Bitcoin
68,509.82
0.00%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. IVERIC bio Inc (ISEE)

  7. IVERIC bio Inc (ISEE) Noticias

ISEE

IVERIC bio (ISEE)

IVERIC bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ISEE
FechaHoraFuenteTítuloSímboloCompañía
14/02/202407:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ISEEIVERIC bio Inc
21/07/202307:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ISEEIVERIC bio Inc
17/07/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ISEEIVERIC bio Inc
13/07/202313:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
11/07/202318:00PR Newswire (US)Astellas Completes Acquisition of Iveric BioNASDAQ:ISEEIVERIC bio Inc
11/07/202309:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202309:01Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:ISEEIVERIC bio Inc
11/07/202308:57Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ISEEIVERIC bio Inc
11/07/202308:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ISEEIVERIC bio Inc
05/07/202315:05Business WireIveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ISEEIVERIC bio Inc
29/06/202315:58Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ISEEIVERIC bio Inc
29/06/202315:57Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ISEEIVERIC bio Inc
28/06/202317:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ISEEIVERIC bio Inc
05/06/202307:54Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:ISEEIVERIC bio Inc
02/06/202315:28Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ISEEIVERIC bio Inc
17/05/202315:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ISEEIVERIC bio Inc
10/05/202306:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ISEEIVERIC bio Inc
01/05/202306:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ISEEIVERIC bio Inc
30/04/202319:57Dow Jones NewsAstellas Pharma to Buy Iveric Bio for About $5.9 BillionNASDAQ:ISEEIVERIC bio Inc
30/04/202318:00Business WireAstellas Enters Into Definitive Agreement to Acquire Iveric BioNASDAQ:ISEEIVERIC bio Inc
30/04/202318:00PR Newswire (US)Astellas Enters into Definitive Agreement to Acquire Iveric BioNASDAQ:ISEEIVERIC bio Inc
23/04/202316:15Business WireIveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trials Presented at ARVO Annual MeetingNASDAQ:ISEEIVERIC bio Inc
06/04/202315:25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ISEEIVERIC bio Inc
05/04/202315:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ISEEIVERIC bio Inc
01/03/202315:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ISEEIVERIC bio Inc
01/03/202305:32Business WireIveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial ResultsNASDAQ:ISEEIVERIC bio Inc
01/03/202305:30Business WireIveric Bio Announces Vision Loss Reduction Data in Geographic Atrophy from Avacincaptad Pegol GATHER TrialsNASDAQ:ISEEIVERIC bio Inc
28/02/202307:00Business WireIveric Bio to Present at the Cowen 43rd Annual Health Care ConferenceNASDAQ:ISEEIVERIC bio Inc
22/02/202307:00Business WireIveric Bio to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on Wednesday, March 1, 2023NASDAQ:ISEEIVERIC bio Inc
17/02/202309:54Dow Jones NewsIveric Bio Shares Rise 16% After FDA Accepts New Drug App for Avacincaptad PegolNASDAQ:ISEEIVERIC bio Inc
 Showing the most relevant articles for your search:NASDAQ:ISEE

Su Consulta Reciente

BIT
SCAC7S
Societe Generale Effekten
AQSE
LQDE.GB
iShares USD Corp Bond UC...
BOV
LOGG3M
LOG Commercial ON
EU
D156T
D156T
BIT
UB03T3
UniCredit Bank
NASDAQ
FSYJX
Fidelity Sustainable Eme...
BOV
SOMA3M
Grupo De Moda Soma ON
COIN
ECOSBTC
TSXV
WI
The Western Investment C...
COIN
RCNUSAEUR
COIN
DSSUSD
DssToken
BIT
CO2L1
Sg Etc Carbon Future
MRTX
BITXETH
BITIFEX
EU
BE0002882638
KBC Bank NV Kbcbk2.375%2...
LSE
CRMS
Ls -1x Crm
NASDAQ
ISTR
Investar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados